The Role of Breast MRI in the Management of Patients with Breast Disease

Claire S. Cooney, Nagi Fouad Khouri, Theodore N Tsangaris

Research output: Contribution to journalArticle

Abstract

Breast MRI has paved the way for new thinking regarding the workup of women recently diagnosed with breast cancer and the screening of high-risk women. The routine use of MRI preoperatively is advocated, particularly in young patients and women with dense breasts where mammography is significantly less sensitive for the detection of malignancy. Additionally, MRI is particularly helpful in those women who have core biopsy results showing extensive intraductal component (>25%) or invasive lobular carcinoma, and in those women with increased risk of positive margins. However, as with any imaging modality, breast magnetic resonance has limitations. Because breast magnetic resonance has lower specificity than some modalities, clinicians must be selective in identifying those women most likely to benefit from this additional imaging. Many recent publications show that MRI does not unduly raise the false-positive biopsy rate while providing specificity similar to that of mammography and higher than that of ultrasound. Positive margin rates for breast conservation therapy range from 30% to 50% and the achievement of negative margins is directly related to low recurrence rates. Magnetic resonance provides improved preoperative staging, which in turn may reduce recurrence rates and improve patient outcome. Breast MRI should be used in concert with other modalities, such as mammography and ultrasound, for the highest sensitivity for detecting malignancy. Long-term studies are needed to validate the impact of screening and diagnostic breast MRI on patient outcomes.

Original languageEnglish (US)
Pages (from-to)299-312
Number of pages14
JournalAdvances in Surgery
Volume42
Issue numberC
DOIs
StatePublished - Sep 2008

Fingerprint

Breast Diseases
Breast
Mammary Ultrasonography
Magnetic Resonance Spectroscopy
Lobular Carcinoma
Biopsy
Recurrence
Segmental Mastectomy
Mammography
Early Detection of Cancer
Neoplasms
Breast Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

The Role of Breast MRI in the Management of Patients with Breast Disease. / Cooney, Claire S.; Khouri, Nagi Fouad; Tsangaris, Theodore N.

In: Advances in Surgery, Vol. 42, No. C, 09.2008, p. 299-312.

Research output: Contribution to journalArticle

Cooney, Claire S. ; Khouri, Nagi Fouad ; Tsangaris, Theodore N. / The Role of Breast MRI in the Management of Patients with Breast Disease. In: Advances in Surgery. 2008 ; Vol. 42, No. C. pp. 299-312.
@article{39b8e24e52bb4d37b303a484a2dac5f4,
title = "The Role of Breast MRI in the Management of Patients with Breast Disease",
abstract = "Breast MRI has paved the way for new thinking regarding the workup of women recently diagnosed with breast cancer and the screening of high-risk women. The routine use of MRI preoperatively is advocated, particularly in young patients and women with dense breasts where mammography is significantly less sensitive for the detection of malignancy. Additionally, MRI is particularly helpful in those women who have core biopsy results showing extensive intraductal component (>25{\%}) or invasive lobular carcinoma, and in those women with increased risk of positive margins. However, as with any imaging modality, breast magnetic resonance has limitations. Because breast magnetic resonance has lower specificity than some modalities, clinicians must be selective in identifying those women most likely to benefit from this additional imaging. Many recent publications show that MRI does not unduly raise the false-positive biopsy rate while providing specificity similar to that of mammography and higher than that of ultrasound. Positive margin rates for breast conservation therapy range from 30{\%} to 50{\%} and the achievement of negative margins is directly related to low recurrence rates. Magnetic resonance provides improved preoperative staging, which in turn may reduce recurrence rates and improve patient outcome. Breast MRI should be used in concert with other modalities, such as mammography and ultrasound, for the highest sensitivity for detecting malignancy. Long-term studies are needed to validate the impact of screening and diagnostic breast MRI on patient outcomes.",
author = "Cooney, {Claire S.} and Khouri, {Nagi Fouad} and Theodore N Tsangaris",
year = "2008",
month = "9",
doi = "10.1016/j.yasu.2008.03.003",
language = "English (US)",
volume = "42",
pages = "299--312",
journal = "Advances in Surgery",
issn = "0065-3411",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - The Role of Breast MRI in the Management of Patients with Breast Disease

AU - Cooney, Claire S.

AU - Khouri, Nagi Fouad

AU - Tsangaris, Theodore N

PY - 2008/9

Y1 - 2008/9

N2 - Breast MRI has paved the way for new thinking regarding the workup of women recently diagnosed with breast cancer and the screening of high-risk women. The routine use of MRI preoperatively is advocated, particularly in young patients and women with dense breasts where mammography is significantly less sensitive for the detection of malignancy. Additionally, MRI is particularly helpful in those women who have core biopsy results showing extensive intraductal component (>25%) or invasive lobular carcinoma, and in those women with increased risk of positive margins. However, as with any imaging modality, breast magnetic resonance has limitations. Because breast magnetic resonance has lower specificity than some modalities, clinicians must be selective in identifying those women most likely to benefit from this additional imaging. Many recent publications show that MRI does not unduly raise the false-positive biopsy rate while providing specificity similar to that of mammography and higher than that of ultrasound. Positive margin rates for breast conservation therapy range from 30% to 50% and the achievement of negative margins is directly related to low recurrence rates. Magnetic resonance provides improved preoperative staging, which in turn may reduce recurrence rates and improve patient outcome. Breast MRI should be used in concert with other modalities, such as mammography and ultrasound, for the highest sensitivity for detecting malignancy. Long-term studies are needed to validate the impact of screening and diagnostic breast MRI on patient outcomes.

AB - Breast MRI has paved the way for new thinking regarding the workup of women recently diagnosed with breast cancer and the screening of high-risk women. The routine use of MRI preoperatively is advocated, particularly in young patients and women with dense breasts where mammography is significantly less sensitive for the detection of malignancy. Additionally, MRI is particularly helpful in those women who have core biopsy results showing extensive intraductal component (>25%) or invasive lobular carcinoma, and in those women with increased risk of positive margins. However, as with any imaging modality, breast magnetic resonance has limitations. Because breast magnetic resonance has lower specificity than some modalities, clinicians must be selective in identifying those women most likely to benefit from this additional imaging. Many recent publications show that MRI does not unduly raise the false-positive biopsy rate while providing specificity similar to that of mammography and higher than that of ultrasound. Positive margin rates for breast conservation therapy range from 30% to 50% and the achievement of negative margins is directly related to low recurrence rates. Magnetic resonance provides improved preoperative staging, which in turn may reduce recurrence rates and improve patient outcome. Breast MRI should be used in concert with other modalities, such as mammography and ultrasound, for the highest sensitivity for detecting malignancy. Long-term studies are needed to validate the impact of screening and diagnostic breast MRI on patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=49949101650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49949101650&partnerID=8YFLogxK

U2 - 10.1016/j.yasu.2008.03.003

DO - 10.1016/j.yasu.2008.03.003

M3 - Article

C2 - 18953825

AN - SCOPUS:49949101650

VL - 42

SP - 299

EP - 312

JO - Advances in Surgery

JF - Advances in Surgery

SN - 0065-3411

IS - C

ER -